Business, energy, technology, markets and global industry news from Business News Today

advanced melanoma

PharmaDeviceNews advanced melanoma
Pharma & Biotech

Obsidian Therapeutics puts OBX-115 in the spotlight, but is this a real melanoma cell therapy inflection point?

Obsidian Therapeutics will present OBX-115 melanoma data at ASCO 2026. Read why the update matters for TIL therapy, scalability, and solid tumor strategy.

Read More
Pharma & Biotech

Scancell’s late-stage push for iSCIB1+ reframes the risk calculus in advanced melanoma trials

FDA clears Scancell’s iSCIB1+ for Phase 3 testing in advanced melanoma. Discover what this means for immunotherapy risk, trial design, and competition.

Read More
Medical Devices & Diagnostics

PharmaJet’s needle-free system to power Scancell’s melanoma Phase 3 after strong DNA therapy data

PharmaJet’s needle-free device will deliver Scancell’s DNA immunotherapy in a Phase 3 melanoma trial. Find out what this means for the future of cancer vaccines.

Read More